Literature DB >> 3207562

An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.

R J Riley1, J L Maggs, C Lambert, N R Kitteringham, B K Park.   

Abstract

1. The cytotoxicity of metabolites generated from phenytoin, sorbinil and mianserin by human and mouse liver microsomes was assessed by co-incubation with human mononuclear leucocytes as target cells. Cytotoxicity was determined by trypan blue dye exclusion. 2. Phenytoin and sorbinil were metabolised by NADPH-dependent murine microsomal enzymes to cytotoxic metabolites. Cytotoxicity produced by both drugs was significantly enhanced by the epoxide hydrolase inhibitor trichloropropane oxide (TCPO). No significant cytotoxicity was observed in the presence of human liver microsomes. 3. Mianserin was metabolised by both human and mouse liver microsomes to a cytotoxin. Cytotoxicity was greater in the presence of human liver microsomes (13.7 +/- 2.2%; mean +/- s.d. for four livers, compared with 6.0 +/- 2.4%, mean +/- s.d., n = 4, with mouse liver microsomes), and was unaffected by pretreatment with TCPO. 4. Stable metabolites were quantified by radiometric high performance liquid chromatography. Phenytoin and sorbinil were metabolised to 5-(p-hydroxyphenyl)-5-phenyl-hydantoin (0.3-0.5% of incubated radioactivity) and 2-hydroxysorbinil (0.4-2.7% of incubated radioactivity), respectively, by both human and mouse liver microsomes. 5. Mianserin was metabolised to 8-hydroxymianserin and desmethylmianserin by both human and mouse liver microsomes. Desmethylmianserin was the major product in incubations with human liver microsomes (32.3 +/- 12%, mean +/- s.d. for four livers), whereas 8-hydroxymianserin was the predominant metabolite generated by mouse liver microsomes (25.9 +/- 1.5%, mean +/- s.d., n = 4). 6. Generation of electrophilic metabolites was assessed by determination of the amount of radiolabelled material which became irreversibly bound to protein. Only mouse liver microsomes activated phenytoin to a chemically reactive metabolite, whereas both mouse and human liver microsomes generated reactive metabolites from sorbinil and mianserin. 7. These studies show that drug cytotoxicity can be mediated by low concentrations (circa microM) of metabolites generated by NADPH-dependent hepatic microsomal enzymes; however demonstration of cytotoxicity in vitro has not been established as a means of predicting in vivo toxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207562      PMCID: PMC1386635          DOI: 10.1111/j.1365-2125.1988.tb05298.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.

Authors:  F Martz; C Failinger; D A Blake
Journal:  J Pharmacol Exp Ther       Date:  1977-10       Impact factor: 4.030

3.  Role of detoxifying enzymes in bromobenzene-induced liver necrosis.

Authors:  N Zampaglione; D J Jollow; J R Mitchell; B Stripp; M Hamrick; J R Gillette
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

4.  Hepatic epoxide hydrase. Structure-activity relationships for substrates and inhibitors.

Authors:  F Oesch; N Kaubisch; D M Jerina; J W Daly
Journal:  Biochemistry       Date:  1971-12-21       Impact factor: 3.162

5.  Drug metabolism in human liver in vitro: establishment of a human liver bank.

Authors:  C von Bahr; C G Groth; H Jansson; G Lundgren; M Lind; H Glaumann
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

6.  Diphenylhydantoin--induced hepatic necrosis.

Authors:  G J Dhar; C A Pierach; P N Ahamed; R B Howard
Journal:  Postgrad Med       Date:  1974-07       Impact factor: 3.840

7.  Metabolic activation and cytotoxicity of cyclophosphamide in primary cultures of postnatal rat hepatocytes.

Authors:  D Acosta; D B Mitchell
Journal:  Biochem Pharmacol       Date:  1981-12-01       Impact factor: 5.858

8.  The metabolism of mianserin in women, rabbits, and rats: identification of the major urinary metabolites.

Authors:  G D de Jongh; H M van den Wildenberg; H Nieuwenhuyse; F van der Veen
Journal:  Drug Metab Dispos       Date:  1981 Jan-Feb       Impact factor: 3.922

9.  Predisposition to phenytoin hepatotoxicity assessed in vitro.

Authors:  S P Spielberg; G B Gordon; D A Blake; D A Goldstein; H F Herlong
Journal:  N Engl J Med       Date:  1981-09-24       Impact factor: 91.245

10.  Acetaminophen toxicity in human lymphocytes in vitro.

Authors:  S P Spielberg
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

View more
  20 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

3.  Using a simple HPLC approach to identify the enzymatic products of UTL-5g, a small molecule TNF-α inhibitor, from porcine esterase and from rabbit esterase.

Authors:  Kenneth Swartz; Yiguan Zhang; Frederick Valeriote; Ben Chen; Jiajiu Shaw
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-09-23       Impact factor: 3.205

4.  Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro.

Authors:  R J Riley; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

5.  Hepatic injury caused by mianserin.

Authors:  K Otani; S Kaneko; H Tasaki; Y Fukushima
Journal:  BMJ       Date:  1989-08-19

6.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

7.  Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.

Authors:  R J Riley; P Roberts; M D Coleman; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

8.  Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

9.  Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.

Authors:  M Pirmohamed; A Graham; P Roberts; D Smith; D Chadwick; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

10.  An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.

Authors:  M D Tingle; M D Coleman; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.